Login
Register
Submit a Paper
Propose a Special lssue
Open Access
RETRACTION
Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
Oncology Research 2026, 34(5), 40 https://doi.org/10.32604/or.2026.081624
Issue published 22 April 2026
This article is a retraction of:
miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
Read original article
View Full Text
Download PDFAbstract
This article has no abstract.Cite This Article
APA Style
Oncology Research Editorial Office (2026). Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. Oncology Research, 34(5), 40. https://doi.org/10.32604/or.2026.081624
Vancouver Style
Oncology Research Editorial Office. Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. Oncol Res. 2026;34(5):40. https://doi.org/10.32604/or.2026.081624
IEEE Style
Oncology Research Editorial Office, “Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2,” Oncol. Res., vol. 34, no. 5, pp. 40, 2026. https://doi.org/10.32604/or.2026.081624
Copyright © 2026 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
